+38 068 889 89 89
00380689869898 (汉语)
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Contact us

News about eye diseases

Induced Pluripotent Stem Cells Hold Promise for Treating Eye Diseases Including Macular Dystrophy

27 August 2015

The researchers tested immune reactions to a variety of cell types derived from human induced pluripotent stem cellsand found out that retinal pigment epithelial cells were tolerated well.

Scientists Use Fat Stem Cells To Prevent Diabetic Blindness

22 August 2015

The recent research by scientists from the University of Virginia School of Medicine shows that stem cells taken from non-diabetics are more promising for treating diabetic blindness than cells taken from patients' own bodies.

Sight Successfully Restored after Stem Cell Treatment

19 October 2014

People with macular degeneration had their eyesight improved after the stem cell transplantation as research by scientists from Massachusetts company Advanced Cell Technology shows.

Japanese Woman is the First to Receive Stem Cell Derived Retinal Tissue Implant to Her Eyes

05 October 2014

For the first time ever, surgeons from the Kobe City Medical Center General Hospital implanted a retinal tissue derived from the patient's own cells that were first reverted to 'pluripotent' state.

Radical Stem Cell Treatment Saves Man's Sight

24 December 2012

A year ago, Canadian Taylor Binns was slowly going blind. Today, he's driving, reading and living a normal life because of a revolutionary stem-cell treatment.

Stem Cells For Restoring Eyesight - New Delivery Method

16 December 2012

A new technique for transporting stem cell therapy to the eye has been developed by a group of engineers at the University of Sheffield, England. They hope this discovery can aid in repairing eyes that have been damaged by disease or accident in a natural way.

10 major pharmas unite in 'pioneering' stem cell effort

08 December 2012

Roche has taken a lead role in rallying 9 other large drugmakers and additional stakeholders to build a major collection of 1,500 induced pluripotent stem cell lines for use in early testing of drugs against a range of neurological ailments as well as diabetes.

prev 123 next